|
1
|
Sar P, Peter R, Rath B, Das Mohapatra A
and Mishra SK: 3,3′5 Triiodo L thyronine induces apoptosis in human
breast cancer MCF-7 cells, repressing SMP30 expression through
negative thyroid response elements. PLoS One. 6:e208612011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheng SY, Leonard JL and Davis PJ:
Molecular aspects of thyroid hormone actions. Endocr Rev.
31:139–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bassett JH, Harvey CB and Williams GR:
Mechanisms of thyroid hormone receptor-specific nuclear and extra
nuclearactions. Mol Cell Endocrinol. 213:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paquette MA, Atlas E, Wade MG and Yauk CL:
Thyroid hormone response element half-site organization and its
effect on thyroid hormone mediated transcription. PLoS One.
9:e1011552014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu L, Tian G, Yang Q, De G, Zhang Z, Wang
Y, Nie H, Zhang Y, Yang X and Li J: Thyroid hormone receptor β1
suppresses proliferation and migration by inhibiting PI3K/Akt
signaling in human colorectal cancer cells. Oncol Rep.
36:1419–1426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ling Y, Shi X, Wang Y, Ling X and Li Q:
Down-regulation of thyroid hormone receptor β1 gene expression in
gastric cancer involves promoter methylation. Biochem Biophys Res
Commun. 444:147–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosignolo F, Maggisano V, Sponziello M,
Celano M, Di Gioia CR, D'Agostino M, Giacomelli L, Verrienti A,
Dima M, Pecce V and Durante C: Reduced expression of THRβ in
papillary thyroid carcinomas: Relationship with BRAF mutation,
aggressiveness and miR expression. J Endocrinol Invest.
38:1283–1289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guigon CJ, Kim DW, Willingham MC and Cheng
SY: Mutation of thyroid hormone receptor-β in mice predisposes to
the development of mammary tumors. Oncogene. 30:3381–3390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park JW, Zhao L, Willingham M and Cheng
SY: Oncogenic mutations of thyroid hormone receptor β. Oncotarget.
6:8115–8131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim WG, Zhao L, Kim DW, Willingham MC and
Cheng SY: Inhibition of tumorigenesis by the thyroid hormone
receptor β in xenograft models. Thyroid. 24:260–269. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao RL, Sun B, Liu Y, Li JH, Xiong WL,
Liang DC, Guo G, Zuo AJ and Zhang JY: Cloning and identification of
a novel thyroid hormone receptor β isoform expressed in the
pituitary gland. Mol Cell Biochem. 389:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao RL, Song W, Sun YL, Li Q, Li M, Chu
HR and Peng XX: Effects of thyroid hormone receptor βΔ on apoptosis
and proliferation of hepatoma RH-35 cells. Chin J Endocrinol Metab.
32:691–695. 2016.
|
|
13
|
Zhang YY, Peng XX, Sun YL, Song W and Zhao
RL: Effect of thyroid hormone receptor βΔ on proliferation and
apoptosis of rat breast cancer cells SHZ-88. Cancer Res Prev Treat.
43:1018–1022. 2016.
|
|
14
|
Zhao R, Sun B, Liu T, Liu Y, Zhou S, Zuo A
and Liang D: Optimize nuclear localization and intra-nucleus
disassociation of the exogenefor facilitating transfection efficacy
of the chitosan. Int J Pharm. 413:254–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones I, Srinivas M, Ng L and Forrest D:
The thyroid hormone receptor beta gene: Structure and functions in
the brain and sensory systems. Thyroid. 13:1057–1068. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cryns V and Yuan J: Proteases to die for.
Genes Dev. 12:1551–1570. 1988. View Article : Google Scholar
|
|
18
|
Guo W, Zhang Y, Ling Z, Liu X, Zhao X,
Yuan Z, Nie C and Wei Y: Caspase-3 feedback loop enhances
Bid-induced AIF/endoG and Bak activationin Bax and p53-independent
manner. Cell Death Dis. 6:e19192015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ruiz-Llorente L, Ardila-González S, Fanjul
LF, Martínez-Iglesias O and Aranda A: microRNAs 424 and 503 are
mediators of the anti-proliferative and anti-invasive action of the
thyroid hormone receptor beta. Oncotarget. 5:2918–2933. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park JW, Zhao L and Cheng SY: Inhibition
of estrogen-dependent tumorigenesis by the thyroid hormonereceptor
β in xenograft models. Am J Cancer Res. 3:302–311. 2013.PubMed/NCBI
|
|
21
|
de Sibio MT, de Oliveira M, Moretto FC,
Olimpio RM, Conde SJ, Luvizon AC and Nogueira CR: Triiodothyronine
and breast cancer. World J Clin Oncol. 5:503–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Meng ZH, Chandrasekaran R, Kuo WL,
Collins CC, Gray JW and Dairkee SH: Biallelic inactivation of the
thyroid hormone receptor beta1 gene in earlystage breast cancer.
Cancer Res. 62:1939–1943. 2002.PubMed/NCBI
|
|
23
|
Jazdzewski K, Boguslawska J, Jendrzejewski
J, Liyanarachchi S, Pachucki J, Wardyn KA, Nauman A and de la
Chapelle A: Thyroid hormone receptor beta (THRB) is a major target
gene for microRNAs deregulated in papillary thyroid carcinoma
(PTC). J Clin Endocrinol Metab. 96:E546–E553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nelson CC, Hendy SC, Faris JS and Romaniuk
PJ: Retinoid X receptor alters the Determination of DNA binding
specificity by the P-box amino acids of the thyroid hormone
receptor. J Biol Chem. 271:19464–19474. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Figueira AC, Lima LM, Lima LH, Ranzani AT,
Mule Gdos S and Polikarpov I: Recognition by the thyroid hormone
receptor of canonical DNA response elements. Biochemistry.
49:893–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berglund H, Wolf-Watz M, Lundbäck T, van
den Berg S and Härd T: Structure and dynamics of the glucocorticoid
receptor DNA-binding domain: Comparison of wild type and a mutant
with altered specificity. Biochemistry. 36:11188–11197. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shibusawa N, Hashimoto K, Nikrodhanond AA,
Liberman MC, Applebury ML, Liao XH, Robbins JT, Refetoff S, Cohen
RN and Wondisford FE: Thyroid hormone action in the absence of
thyroid hormone receptor DNA-binding in vivo. J Clin Invest.
112:88–97. 2003. View Article : Google Scholar
|
|
28
|
Shi XZ, Jin X, Xu P and Shen HM:
Relationship between breast cancer and levels of serum thyroid
hormones and antibodies: A meta-analysis. Asian Pac J Cancer Prev.
15:6643–6647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rasool M, Naseer MI, Zaigham K, Malik A,
Riaz N, Alam R, Manan A, Sheikh IA and Asif M: Comparative study of
alterations in Tri-iodothyronine (T3) and Thyroxine (T4) hormone
levels in breast and ovarian cancer. Pak J Med Sci. 30:1356–1360.
2014.PubMed/NCBI
|
|
30
|
Flamini MI, Uzair ID, Pennacchio GE, Neira
FJ, Mondaca JM, Cuello-Carrión FD, Jahn GA, Simoncini T and Sanchez
AM: Thyroid hormone controls breast cancer cell movement via
integrin αV/β3/SRC/FAK/PI3-Kinases. Horm Cancer. 8:16–27. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beatson GT: On the etiology of cancer,
with a note of some experiments. Br Med J. 1:399–400. 1899.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ruiz-Llorente L, Martínez-Iglesias O,
García-Silva S, Tenbaum S, Regadera J and Aranda A: The thyroid
hormone receptors as tumor suppressors. Horm Mol Biol Clin
Investig. 5:79–89. 2011.PubMed/NCBI
|
|
33
|
Gu G, Gelsomino L, Covington KR, Beyer AR,
Wang J, Rechoum Y, Huffman K, Carstens R, Andò S and Fuqua SA:
Targeting thyroid hormone receptor beta in triple-negative breast
cancer. Breast Cancer Res Treat. 150:535–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
